Detection of interleukin-1 beta in human periapical lesions

R A Barkhordar1, M Z Hussain, C Hayashi

  • 1Department of Restorative Dentistry, School of Dentistry, University of California, San Francisco.

Insights

Interleukin-1 beta (IL-1 beta), a key inflammatory mediator, was detected in human periapical lesions. This finding suggests IL-1 beta plays a role in the bone resorption associated with these lesions.

Area of Science:

  • Oral biology
  • Immunology
  • Bone physiology

Background:

  • Interleukins modulate bone cell activity, with Interleukin-1 (IL-1) stimulating bone resorption.
  • Monocytes and macrophages are primary producers of IL-1.
  • Periapical lesions contain diverse inflammatory cells.

Purpose of the Study:

  • To detect Interleukin-1 beta (IL-1 beta) activity in human periapical lesions.
  • To investigate the role of IL-1 beta in periapical bone resorption.

Main Methods:

  • Eight human periapical lesions and control pulp tissues were analyzed.
  • Specimens were quick-frozen and stored in liquid nitrogen.
  • IL-1 beta activity was quantified using a specific enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • Significant IL-1 beta activity was found in periapical samples (mean 604.4 +/- 563.0 pg/mg protein).
  • Normal pulp tissue exhibited no detectable IL-1 beta activity.
  • A strong correlation between IL-1 beta presence and bone resorption was implied.

Conclusions:

  • Interleukin-1 beta is locally produced and released within inflammatory periapical lesions.
  • IL-1 beta is a key mediator of bone resorption in periapical disease.
  • Targeting IL-1 beta may offer therapeutic strategies for periapical lesions.

Related Concept Videos